BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27300767)

  • 1. G6PC2 Modulates Fasting Blood Glucose In Male Mice in Response to Stress.
    Boortz KA; Syring KE; Dai C; Pound LD; Oeser JK; Jacobson DA; Wang JC; McGuinness OP; Powers AC; O'Brien RM
    Endocrinology; 2016 Aug; 157(8):3002-8. PubMed ID: 27300767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G6PC2 Modulates the Effects of Dexamethasone on Fasting Blood Glucose and Glucose Tolerance.
    Boortz KA; Syring KE; Lee RA; Dai C; Oeser JK; McGuinness OP; Wang JC; O'Brien RM
    Endocrinology; 2016 Nov; 157(11):4133-4145. PubMed ID: 27653037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic islet beta cell-specific deletion of G6pc2 reduces fasting blood glucose.
    Bosma KJ; Rahim M; Singh K; Goleva SB; Wall ML; Xia J; Syring KE; Oeser JK; Poffenberger G; McGuinness OP; Means AL; Powers AC; Li WH; Davis LK; Young JD; O'Brien RM
    J Mol Endocrinol; 2020 May; 64(4):235-248. PubMed ID: 32213654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of
    Boortz KA; Syring KE; Pound LD; Mo H; Bastarache L; Oeser JK; McGuinness OP; Denny JC; O'Brien RM
    J Mol Endocrinol; 2017 Apr; 58(3):127-139. PubMed ID: 28122818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G6PC2 confers protection against hypoglycemia upon ketogenic diet feeding and prolonged fasting.
    Bosma KJ; Rahim M; Oeser JK; McGuinness OP; Young JD; O'Brien RM
    Mol Metab; 2020 Nov; 41():101043. PubMed ID: 32569842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving on from GWAS: functional studies on the G6PC2 gene implicated in the regulation of fasting blood glucose.
    O'Brien RM
    Curr Diab Rep; 2013 Dec; 13(6):768-77. PubMed ID: 24142592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Enhancer Within Abcb11 Regulates G6pc2 in C57BL/6 Mouse Pancreatic Islets.
    Keller MP; Hawes EM; Schueler KL; Stapleton DS; Mitok KA; Simonett SP; Oeser JK; Sampson LL; Attie AD; Magnuson MA; O'Brien RM
    Diabetes; 2023 Nov; 72(11):1621-1628. PubMed ID: 37552875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-6-phosphatase catalytic subunit 2 negatively regulates glucose oxidation and insulin secretion in pancreatic β-cells.
    Rahim M; Nakhe AY; Banerjee DR; Overway EM; Bosma KJ; Rosch JC; Oeser JK; Wang B; Lippmann ES; Jacobson DA; O'Brien RM; Young JD
    J Biol Chem; 2022 Apr; 298(4):101729. PubMed ID: 35176280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G6PC2: a negative regulator of basal glucose-stimulated insulin secretion.
    Pound LD; Oeser JK; O'Brien TP; Wang Y; Faulman CJ; Dadi PK; Jacobson DA; Hutton JC; McGuinness OP; Shiota M; O'Brien RM
    Diabetes; 2013 May; 62(5):1547-56. PubMed ID: 23274894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsynonymous single-nucleotide polymorphisms in the G6PC2 gene affect protein expression, enzyme activity, and fasting blood glucose.
    Overway EM; Bosma KJ; Claxton DP; Oeser JK; Singh K; Breidenbach LB; Mchaourab HS; Davis LK; O'Brien RM
    J Biol Chem; 2022 Feb; 298(2):101534. PubMed ID: 34954144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel stable isotope analyses demonstrate significant rates of glucose cycling in mouse pancreatic islets.
    Wall ML; Pound LD; Trenary I; O'Brien RM; Young JD
    Diabetes; 2015 Jun; 64(6):2129-37. PubMed ID: 25552595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Analysis of Mouse G6pc1 Mutations Using a Novel In Situ Assay for Glucose-6-Phosphatase Activity and the Effect of Mutations in Conserved Human G6PC1/G6PC2 Amino Acids on G6PC2 Protein Expression.
    Boortz KA; Syring KE; Pound LD; Wang Y; Oeser JK; O'Brien RM
    PLoS One; 2016; 11(9):e0162439. PubMed ID: 27611587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and functional assessment of the role of the rs13431652-A and rs573225-A alleles in the G6PC2 promoter that are strongly associated with elevated fasting glucose levels.
    Bouatia-Naji N; Bonnefond A; Baerenwald DA; Marchand M; Bugliani M; Marchetti P; Pattou F; Printz RL; Flemming BP; Umunakwe OC; Conley NL; Vaxillaire M; Lantieri O; Balkau B; Marre M; Lévy-Marchal C; Elliott P; Jarvelin MR; Meyre D; Dina C; Oeser JK; Froguel P; O'Brien RM
    Diabetes; 2010 Oct; 59(10):2662-71. PubMed ID: 20622168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels.
    Baerenwald DA; Bonnefond A; Bouatia-Naji N; Flemming BP; Umunakwe OC; Oeser JK; Pound LD; Conley NL; Cauchi S; Lobbens S; Eury E; Balkau B; Lantieri O; ; Dadi PK; Jacobson DA; Froguel P; O'Brien RM
    Diabetologia; 2013 Jun; 56(6):1306-16. PubMed ID: 23508304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
    Tam CH; Ho JS; Wang Y; Lee HM; Lam VK; Germer S; Martin M; So WY; Ma RC; Chan JC; Ng MC
    PLoS One; 2010 Jul; 5(7):e11428. PubMed ID: 20628598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physiological effects of deleting the mouse SLC30A8 gene encoding zinc transporter-8 are influenced by gender and genetic background.
    Pound LD; Sarkar SA; Ustione A; Dadi PK; Shadoan MK; Lee CE; Walters JA; Shiota M; McGuinness OP; Jacobson DA; Piston DW; Hutton JC; Powell DR; O'Brien RM
    PLoS One; 2012; 7(7):e40972. PubMed ID: 22829903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes.
    Shi Y; Li Y; Wang J; Wang C; Fan J; Zhao J; Yin L; Liu X; Zhang D; Li L
    PLoS One; 2017; 12(7):e0181232. PubMed ID: 28704540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11).
    Zusi C; Rinaldi E; Bonetti S; Boselli ML; Trabetti E; Malerba G; Bonora E; Bonadonna RC; Trombetta M
    J Endocrinol Invest; 2021 Dec; 44(12):2567-2574. PubMed ID: 34128214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose.
    Li X; Shu YH; Xiang AH; Trigo E; Kuusisto J; Hartiala J; Swift AJ; Kawakubo M; Stringham HM; Bonnycastle LL; Lawrence JM; Laakso M; Allayee H; Buchanan TA; Watanabe RM
    Diabetes; 2009 Dec; 58(12):2946-53. PubMed ID: 19741163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analysis identifies CpGs near G6PC2 mediating the effects of genetic variants on fasting glucose.
    Chung RH; Chiu YF; Wang WC; Hwu CM; Hung YJ; Lee IT; Chuang LM; Quertermous T; Rotter JI; Chen YI; Chang IS; Hsiung CA
    Diabetologia; 2021 Jul; 64(7):1613-1625. PubMed ID: 33842983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.